SCHEDULE: Vanguard Group Amends Hinge Health Ownership Disclosure
Schedule 13G Amendment
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Hinge Health Inc. following an internal realignment.
Summary
- The Vanguard Group, Inc. filed an Amendment No. 1 to its Schedule 13G regarding Hinge Health Inc. common stock.
- The filing reports that The Vanguard Group now holds 0% beneficial ownership in Hinge Health Inc.
- This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of Vanguard will now report their beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
- The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Hinge Health Inc.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It is a technical regulatory update regarding an institutional investor's internal reporting structure, not an operational or financial update for Hinge Health Inc.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
Industry Context
StockSavvy.ai notes that this filing reflects a technical change in how a major institutional investor, The Vanguard Group, reports its beneficial ownership across its various entities. Such internal realignments are not uncommon for large asset managers and typically do not indicate a change in investment strategy or sentiment towards the underlying issuer, Hinge Health Inc., but rather a shift in regulatory reporting methodology.
Stakeholder Impact
- Shareholders: May need to track beneficial ownership of Hinge Health Inc. by Vanguard's subsidiaries separately, rather than solely through The Vanguard Group's aggregate filings.
- Regulatory Authorities: The SEC will receive disaggregated beneficial ownership reports from Vanguard's subsidiaries, aligning with SEC Release No. 34-39538.
Key Dates
| Date | Description |
|---|---|
| 1998-01-12 | Date of SEC Release No. 34-39538, which provides guidance on beneficial ownership reporting. |
| 2026-01-12 | Date of The Vanguard Group, Inc.'s internal realignment, leading to disaggregated beneficial ownership reporting. |
| 2026-03-13 | Date of event which requires filing of this statement (likely the effective date of the reporting change for Hinge Health shares). |
| 2026-03-27 | Date the Schedule 13G/A was signed by The Vanguard Group. |
Keywords
Schedule 13G, Vanguard Group, Hinge Health Inc, Beneficial Ownership, Institutional Investor, SEC Filing, Common Stock, Reporting Change
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.